Medicare Enrolled
Dr. Robert Pecha, M.D.
Optician · Folsom, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pecha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pecha?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pecha
Dr. Robert Pecha is an optician specialist in Folsom, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pecha performed 2,461 Medicare services across 1,663 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pecha received a total of $11,671 from 46 pharmaceutical and/or device companies across 600 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pecha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 32% volume in CA
$11,671 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,461
Medicare services
Top 32% in CA for optician
1,663
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~130 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
767 | $31 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
371 | $96 | $275 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
199 | $103 | $275 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
154 | $54 | $575 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
149 | $98 | $715 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
112 | $217 | $1,265 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
102 | $120 | $350 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
77 | $40 | $115 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
75 | $85 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
74 | $58 | $190 |
| External hemorrhoid removal by rubber banding A procedure to remove external hemorrhoids using rubber bands to cut off blood supply. The affected tissue is tied off and eventually falls off. |
60 | $241 | $400 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
50 | $70 | $190 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
46 | $97 | $750 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
40 | $53 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
34 | $99 | $220 |
| Endoscopy of digestive tract Imaging of the digestive tract performed from the inside using an endoscope. |
32 | $648 | $2,000 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
27 | $139 | $420 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
26 | $186 | $660 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
20 | $126 | $675 |
| Stomach outlet dilation via endoscopy A flexible tube with a camera is used to widen the opening at the bottom of the stomach. This procedure helps relieve blockages or narrowing in the stomach outlet. |
18 | $100 | $725 |
| Liver stiffness measurement A non-invasive test that uses ultrasound or similar technology to measure the stiffness of liver tissue. This measurement helps assess the degree of liver fibrosis or scarring. |
15 | $25 | $128 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
13 | $78 | $168 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,671
Total received (2018-2024)
Avg $1,667/year across 7 years
Top 13% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
600
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,652 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,796
2023
$1,707
2022
$1,345
2021
$981
2020
$698
2019
$2,076
2018
$2,068
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$974
Janssen Biotech, Inc.
$411
GENZYME CORPORATION
$280
Madrigal Pharmaceuticals
$215
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$208
Takeda Pharmaceuticals U.S.A., Inc.
$207
Regeneron Healthcare Solutions, Inc.
$109
Intercept Pharmaceuticals, Inc.
$86
Boston Scientific Corporation
$84
PFIZER INC.
$48
Merck Sharp & Dohme LLC
$45
Lilly USA, LLC
$30
Organon Llc
$23
VIVUS LLC
$21
Braintree Laboratories, Inc.
$19
Celltrion USA Inc.
$18
Gilead Sciences, Inc.
$18
Top 3 companies account for 59.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,127
Janssen Biotech, Inc.
$1,339
Takeda Pharmaceuticals U.S.A., Inc.
$1,149
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,049
AbbVie, Inc.
$853
GENZYME CORPORATION
$732
AbbVie Inc.
$520
Gilead Sciences, Inc.
$466
PFIZER INC.
$379
Allergan Inc.
$366
QOL Medical, LLC
$295
Celgene Corporation
$250
Madrigal Pharmaceuticals
$215
Merck Sharp & Dohme Corporation
$209
Regeneron Healthcare Solutions, Inc.
$172
Boston Scientific Corporation
$133
Synergy Pharmaceuticals Inc
$126
Braintree Laboratories, Inc.
$114
Ironwood Pharmaceuticals, Inc
$108
Daiichi Sankyo Inc.
$103
Nestle HealthCare Nutrition Inc.
$102
Intercept Pharmaceuticals, Inc.
$86
Merck Sharp & Dohme LLC
$67
NESTLE HEALTHCARE NUTRITION INC.
$64
Olympus America Inc.
$55
Romark Laboratories, LC
$55
INTERCEPT PHARMACEUTICALS, INC.
$52
Ardelyx, Inc.
$50
Shionogi Inc
$46
Ferring Pharmaceuticals Inc.
$46
Exact Sciences Corporation
$37
Prometheus Laboratories Inc.
$35
BOSTON SCIENTIFIC CORPORATION
$33
Lilly USA, LLC
$30
Alfasigma USA, Inc.
$28
Organon Llc
$23
UCB, Inc.
$22
VIVUS LLC
$21
Celltrion USA Inc.
$18
Shire North American Group Inc
$17
Otsuka America Pharmaceutical, Inc.
$16
Alexion Pharmaceuticals, Inc.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Medline Industries, Inc.
$12
Organon LLC
$12
Aries Pharmaceuticals, Inc.
$11
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
APRISO · Alinia Tablets 500mg 30 count bottle · Amitiza · BREATHTEK · CAPTIVATOR · CIMZIA · CLENPIQ · CREON · CYLTEZO · Cimzia · Cologuard Collection Kit · Creon · DIFICID · DUPIXENT · Dexilant · ELEVIEW · ENTYVIO · EOHILIA · Entyvio · Epclusa · GATTEX · GENERAL - BIOPSY · GENERAL GI DILATATION · HADLIMA · HUMIRA · Humira · IBSRELA · INJECTAFER · IV Catheters by Medline · Kanuma · Koala · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Motegrity · Mulpleta · OCALIVA · OMVOH · Olympus GI Accessories · Olympus Hemostasis Devices · OrcaPod · PANCREAZE · RENFLEXIS · RESMETIROM · REZDIFFRA · RINVOQ · SIMPONI · SKYRIZI · STELARA · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · Symproic · TREMFYA · TRULANCE · Trulance · UCERIS TABLETS · VIBERZI · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPATIER · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
412
Per 100K population
26.0
County median income
$88,724
Nearest hospital
MERCY HOSPITAL OF FOLSOM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pecha is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 13% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pecha experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Pecha performed 767 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pecha receive payments from pharmaceutical companies?
Yes. Dr. Pecha received a total of $11,671 from 46 companies across 600 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pecha's costs compare to other opticians in Folsom?
Dr. Pecha's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pecha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Folsom
Browse opticians in Folsom ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology